Imara

Forma Therapeutics

This company develops medicines for patients with sickle cell disease and rare blood disorders.

IMMvention Therapeutics

This biotechnology firm develops small molecule oral therapies for patients with sickle cell disease and other inflammatory or neurodegenerative conditions.

Bluebird Bio

This company develops and manufactures gene therapies for patients with severe genetic diseases, including sickle cell disease and beta-thalassaemia.

Forma

This company develops small molecule therapies for patients with sickle cell disease and cancer.

Genetix Biotherapeutics

The company develops and commercialises gene therapies for patients suffering from severe rare genetic disorders such as sickle cell disease and beta thalassemia.

Global Blood Therapeutics

This biopharmaceutical company develops and manufactures oral medicines to treat sickle cell disease for patients and healthcare providers.

Imago BioSciences

This biopharmaceutical company develops small molecule inhibitors to treat patients with myeloproliferative neoplasms and other bone marrow diseases.

Disc Medicine

This biopharmaceutical company develops novel therapeutic candidates to treat patients suffering from serious haematologic diseases by targeting red blood cell biology and iron homeostasis.